VectivBio Holding AG Ordinary Shares
VECT
VECT was delisted on the 7th of July, 2023.
25 hedge funds and large institutions have $233M invested in VectivBio Holding AG Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 2 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 26 → 25 (-1)
14% less capital invested
Capital invested by funds: $270M → $233M (-$36.5M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$5.24M |
| 2 |
PCM
Pinz Capital Management
New York
|
+$150K |
| 3 |
CA
CHI Advisors
New York
|
+$56.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$17.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$635K |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$569K |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$308K |
| 4 |
CCM
CAAS Capital Management
New York
|
-$159K |
| 5 |
Millennium Management
New York
|
-$91.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| – | +$266 | +31 | New |
|
VECT Hedge Fund Activity: Q3 2021 in Review
25 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q3 2021, worth a combined $233M — down 14% from $270M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of VECT and 1 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 9 added.
The largest buyer was Tekla Capital Management, adding an estimated $5.24M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $635K sold.
- 25 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q3 2021, down from 26 in Q2 2021.
- Funds reported $233M of VectivBio Holding AG Ordinary Shares stock for Q3 2021, down 14% quarter-over-quarter.
- 1 fund opened new VectivBio Holding AG Ordinary Shares positions in Q3 2021 and 2 closed out, a net change of -1 holder.
- The largest VectivBio Holding AG Ordinary Shares buyer in Q3 2021 was Tekla Capital Management, an estimated $5.24M added.
- The largest VectivBio Holding AG Ordinary Shares seller in Q3 2021 was Monashee Investment Management, an estimated $635K sold.
Based on aggregated 13F filings for Q3 2021.